It has earned a repute of credible reporting, courage, espousal of public interest.
Pages
▼
Monday, April 16, 2012
Piramal Acquires Bayer's Portfolio Rights
Piramal Healthcare today announced its second major acquisition with worldwide rights to the molecular imaging research and development portfolio of Germany’s Bayer Pharma AG.
No comments:
Post a Comment